| Authors: |
Minuti G; Clinical Trials Unit: Phase 1 and Precision Medicine, National Cancer Institute, IRCCS, Regina Elena, Rome, Italy., Pasqualini G; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy., Avancini A; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Italy., Giaj-Levra N; Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don-Calabria, Negrar, Italy., Colonese F; IRCCS San Gerardo dei Tintori, Monza, Italy., Federico AD; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Fozza A; Department of Radiation Oncology, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Montrone M; Medical Thoracic Oncology Unit, Istituto Tumori Giovanni Paolo II, Bari, Italy., Olmetto E; Radiation Oncology Unit, Oncology Department, AOU Careggi Firenze, Firenze, Italy., Pastorello E; Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don-Calabria, Negrar, Italy., Reale ML; Medical Oncology Unit, Vito Fazzi Hospital, Lecce, Italy., Riva ST; IRCCS Ospedale San Raffaele, Department of Medical Oncology, Milan, Italy., Roca E; Thoracic Oncology - Lung Unit, Pederzoli Hospital, Peschiera del Garda, Italy., Sini C; Medical Oncology, Ospedale Giovanni Paolo II - ATS Sardegna - ASSL Olbia, Olbia, Italy., Viscardi G; Department of Pneumology and Oncology, Azienda Ospedaliera di Rilievo Nazionale (AORN) Ospedali dei Colli, Naples, Italy., Pilotto S; Clinical Trials Unit: Phase 1 and Precision Medicine, National Cancer Institute, IRCCS, Regina Elena, Rome, Italy., Passiglia F; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy. Electronic address: francesco.passiglia@unito.it. |
